FDA Approves Roche’ Baloxavir Marboxil To Treat Influenza In Children Aged Five Years And Older

Reuters (8/12, Revill) reported, “Roche has received approval from the U.S. Food and Drugs Administration for its Xofluza [baloxavir marboxil] drug to treat influenza in children aged five years and older, the drugmaker said on Friday.” The drug “has been...